Cite
HARVARD Citation
Platzbecker, U. et al. (2022). Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study. Journal of clinical oncology. 40 (33), pp. 3800-3807. [Online].